|
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy Clinical research trials and Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy. Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy clinical trial. Subjects typically recieve the finest healthcare available for their Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy  Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
For Condition: Neutropenia
Status: No longer recruiting
Sponsor(s): Amgen ,
Synopsis: Physicians are conducting a clinical trial for patients with advanced breast cancer. Breast cancer can be treated with chemotherapy which can affect the bone marrow, where blood cells are produced. Neutrophils are a type of white blood cells that fight infection and are produced in the bone marrow. If the neutrophil count becomes low due to chemotherapy, a potentially serious condition called neutropenia occurs. Neutropenia is serious because it can affect the body's ability to protect against many types of infections. Pegfilgrastim is an investigational drug being evaluated for its potential ability to increase the number of neutrophils. The purpose of this study is to determine the safety and effectiveness of pegfilgrastim in preventing neutropenia following chemotherapy in patients with advanced breast cancer.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Advanced breast cancer - 18 years of age or older - Patients who will be receiving Taxotere (docetaxel) chemotherapy
Total Enrollment: 928
Location and Contact Information:
Research Site
Columbia, Missouri,
United States
Research Site
Plantation, Florida,
United States
Research Site
Tamarac, Florida,
United States
Research Site
Bloomington, Indiana,
United States
Research Site
Long Beach, California,
United States
Research Site
Arlington, Virginia,
United States
Research Site
Brigham City, Utah,
United States
Research Site
Titusville, Florida,
United States
Research Site
Bakersfield, California,
United States
Research Site
Lakewood, Colorado,
United States
Research Site
Azusa, California,
United States
Research Site
Tarpon Springs, Florida,
United States
Research Site
Glendora, California,
United States
Research Site
Southfield, Michigan,
United States
Research Site
Albuquerque, New Mexico,
United States
Research Site
St. Joseph, Michigan,
United States
Research Site
Miami, Florida,
United States
Research Site
Norwich, Connecticut,
United States
Research Site
Poway, California,
United States
Research Site
Philadelphia, Pennsylvania,
United States
Research Site
Soquel, California,
United States
Research Site
Great Neck, New York,
United States
Research Site
Jefferson City, Missouri,
United States
Research Site
Richlands, Virginia,
United States
Research Site
Kissimmee, Florida,
United States
Research Site
Kalamazoo, Michigan,
United States
Research Site
Houston, Texas,
United States
Research Site
Valhalla, New York,
United States
Research Site
Norfolk, Virginia,
United States
Research Site
Ocala, Florida,
United States
Research Site
Logan, Utah,
United States
Research Site
Montgomery, Alabama,
United States
Research Site
Brooklyn, New York,
United States
Research Site
Lancaster, Pennsylvania,
United States
Research Site
Abingdon, Virginia,
United States
Research Site
Arlington Heights, Illinois,
United States
Research Site
St. Joseph, Missouri,
United States
Additional Information:
Study ID Numbers: 20010144;
Study Start Date: February 2002
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035594
Other Neutropenia Studies:
1. Investigating Voriconazole to Prevent Systemic Fungal Infection
2. Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
3. Gene Message (mRNA) Analysis of Granulocytes
4. Cancer in Inherited Bone Marrow Failure Syndromes
5. Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Cyclosporine
Related Studies:
Other Neutropenia Clinical Trials
Other Michigan Clinical Trials
Other St. Joseph Clinical Trials
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
|
|
|
|
|
|
|
|
